Ask a Patient® Health News: Drugs & Treatments

Thanksgiving Weekend Edition: New Lower Drug Prices Announcement from CMS

Dear Readers,

Nov 30

2

Caplyta (lumateperone) Capsules: How a New Approval Can Change a Drug Label in Unexpected Ways

In the Drug Safety Updates newsletter, we usually report on an expanded FDA approval or revised drug safety information with a description and also a…

Nov 17 • 

Katie Rowley

1

November Drug Safety Part 2: Huge Duloxetine and Zyban generic recall; Bupropion-containing meds; Caplyta for major depression; TMS device…

This week, only by coincidence, many of the drugs with an FDA recall or safety update are antidepressant treatments.

Nov 16 • 

Katie Rowley

November 2025 Drug Safety: Recalls for Compounded Semaglutide, Generic Synthroid; Safety Updates for Lamictal, Kineret, Miebo Eye Drops…

Concerns about Industry-funded Studies for GLP-1s

Nov 2 • 

Katie Rowley

3

1

October 2025

Unique Glasses for Kids; Drugs for Common Diseases Get Fast-Tracked; Cancer and Pain Treatment Research; Gabapentin Update; Flu Season News…

This week we're featuring treatments approvals, drug research, pharmacy news, and updates on flu shots. Plus a round-up of three protein supplements…

Oct 19 • 

Katie Rowley

1

1

Huge recall of Glaucoma and Allergy Eye Drops, Recall of Granules' Generic Adderall XR; Acetaminophen Safety; Semaglutide and Serious Eye…

Glaucoma and Allergy Eye Drops Recall by Apotex

Oct 6

2

Note to Readers - Newsletter to be sent October 6

Dear Readers,

Oct 4 • 

Katie Rowley

September 2025

Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad…

Drug Recall: Cyclobenzaprine Hydrochloride

Sep 21 • 

Katie Rowley

3

1

World’s Essential Medicines: What did and didn't make the list; Medical device sterilization dilemma; Eye drops for nearsightedness, Meds…

Notable Updates to “The Selection and Use of Essential Medicines 2025” and more recent consumer-friendly health news.

Sep 7 • 

Katie Rowley

3

1

August 2025

FDA To Tighten Regulation of Natural Thyroid Medications

The FDA announced it is looking at taking action against companies selling “unapproved” animal-based thyroid drugs, but not right away.

Aug 25 • 

Katie Rowley

1

August 2025 Safety Update Part 2: Liver Injury and MS Drugs; Xyzal Warning; Recalls for Metoprolol, Spironolactone, Compounded GLP-1s…

Liver Injury Warnings for MS Drugs

Aug 24

2

August 2025 Drug Safety: Huge Recall of Glaucoma Eye Drops; Duloxetine and Other Generic Recalls; HRT Comments; Opioid and Kratom 7-OH…

Drug Recall: Duloxetine Tablets

Aug 10

5